Glenmark, Sun Pharma, Zydus recall products in US over manufacturing issues

Q: How long will it take to read this news story?

The story "Glenmark, Sun Pharma, Zydus recall products in US over manufacturing issues" has 343 words across 16 sentences, which will take approximately 2 - 3 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Glenmark, Sun Pharma, Zydus recall products in US over manufacturing issues" was covered 1 days ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 204 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #27827535</li><li>URL: https://chronographically.beamstart.com/news/glenmark-sun-pharma-zydus-recall-17445237986461</li></ul>

Business Standard Logo Business Standard 1d ago

Glenmark, Sun Pharma, Zydus recall products in US over manufacturing issues - Business Standard

Quick Summary:

New Jersey-based Glenmark Pharmaceuticals Inc is recalling affected lots of medications like Propafenone Hydrochloride extended-release capsules and Solifenacin Succinate Tablets in America, the USFDA said.

Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.

As per the US health regulator, Mumbai-based Glenmark is recalling over 25 products in the US market due to Current Good Manufacturing Practice (CGMP) deviations.